{"id":"https://openalex.org/W1997113206","doi":"https://doi.org/10.1016/j.neuropharm.2003.10.009","title":"MGS0039: a potent and selective group II metabotropic glutamate receptor antagonist with antidepressant-like activity","display_name":"MGS0039: a potent and selective group II metabotropic glutamate receptor antagonist with antidepressant-like activity","publication_year":2003,"publication_date":"2003-12-30","ids":{"openalex":"https://openalex.org/W1997113206","doi":"https://doi.org/10.1016/j.neuropharm.2003.10.009","mag":"1997113206","pmid":"https://pubmed.ncbi.nlm.nih.gov/14975669"},"language":"en","primary_location":{"id":"doi:10.1016/j.neuropharm.2003.10.009","doi":"https://doi.org/10.1016/j.neuropharm.2003.10.009","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.neuropharm.2003.10.009","pdf_url":null,"source":{"id":"https://openalex.org/S160566677","display_name":"Neuropharmacology","issn_l":"0028-3908","issn":["0028-3908","1873-7064"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-3","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuropharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5039021133","display_name":"Shigeyuki Chaki","orcid":"https://orcid.org/0000-0003-4444-2911","observed_orcids":["https://orcid.org/0000-0003-4444-2911","https://orcid.org/0000-0001-5608-4192"]},"institutions":[{"id":"https://openalex.org/I144245601","display_name":"Taisho Pharmaceutical (Japan)","ror":"https://ror.org/033nw2736","country_code":"JP","type":"company","lineage":["https://openalex.org/I144245601"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Shigeyuki Chaki","raw_affiliation_strings":["Medicinal Research Laboratories, Taisho Pharmaceutical Co., Ltd., Saitama 331-9530, Japan. s.chaki@po.rd.taisho.co.jp","Medicinal Research Laboratories, Taisho Pharmaceutical Co. Ltd., Saitama 331-9530, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicinal Research Laboratories, Taisho Pharmaceutical Co., Ltd., Saitama 331-9530, Japan. s.chaki@po.rd.taisho.co.jp","institution_ids":["https://openalex.org/I144245601"]},{"raw_affiliation_string":"Medicinal Research Laboratories, Taisho Pharmaceutical Co. Ltd., Saitama 331-9530, Japan","institution_ids":["https://openalex.org/I144245601"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111700681","display_name":"Ryoko Yoshikawa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I144245601","display_name":"Taisho Pharmaceutical (Japan)","ror":"https://ror.org/033nw2736","country_code":"JP","type":"company","lineage":["https://openalex.org/I144245601"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Ryoko Yoshikawa","raw_affiliation_strings":["Medicinal Research Laboratories, Taisho Pharmaceutical Co., Ltd., Saitama 331-9530, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicinal Research Laboratories, Taisho Pharmaceutical Co., Ltd., Saitama 331-9530, Japan","institution_ids":["https://openalex.org/I144245601"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066536562","display_name":"Shiho Hirota","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I144245601","display_name":"Taisho Pharmaceutical (Japan)","ror":"https://ror.org/033nw2736","country_code":"JP","type":"company","lineage":["https://openalex.org/I144245601"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Shiho Hirota","raw_affiliation_strings":["Medicinal Research Laboratories, Taisho Pharmaceutical Co., Ltd., Saitama 331-9530, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicinal Research Laboratories, Taisho Pharmaceutical Co., Ltd., Saitama 331-9530, Japan","institution_ids":["https://openalex.org/I144245601"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111583362","display_name":"Toshiharu Shimazaki","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I144245601","display_name":"Taisho Pharmaceutical (Japan)","ror":"https://ror.org/033nw2736","country_code":"JP","type":"company","lineage":["https://openalex.org/I144245601"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Toshiharu Shimazaki","raw_affiliation_strings":["Medicinal Research Laboratories, Taisho Pharmaceutical Co., Ltd., Saitama 331-9530, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicinal Research Laboratories, Taisho Pharmaceutical Co., Ltd., Saitama 331-9530, Japan","institution_ids":["https://openalex.org/I144245601"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078412178","display_name":"Maoko Maeda","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I144245601","display_name":"Taisho Pharmaceutical (Japan)","ror":"https://ror.org/033nw2736","country_code":"JP","type":"company","lineage":["https://openalex.org/I144245601"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Maoko Maeda","raw_affiliation_strings":["Medicinal Research Laboratories, Taisho Pharmaceutical Co., Ltd., Saitama 331-9530, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicinal Research Laboratories, Taisho Pharmaceutical Co., Ltd., Saitama 331-9530, Japan","institution_ids":["https://openalex.org/I144245601"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110697914","display_name":"Naoya Kawashima","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I144245601","display_name":"Taisho Pharmaceutical (Japan)","ror":"https://ror.org/033nw2736","country_code":"JP","type":"company","lineage":["https://openalex.org/I144245601"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Naoya Kawashima","raw_affiliation_strings":["Medicinal Research Laboratories, Taisho Pharmaceutical Co., Ltd., Saitama 331-9530, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicinal Research Laboratories, Taisho Pharmaceutical Co., Ltd., Saitama 331-9530, Japan","institution_ids":["https://openalex.org/I144245601"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031756897","display_name":"Takao Yoshimizu","orcid":"https://orcid.org/0000-0002-2553-8195","observed_orcids":["https://orcid.org/0000-0002-2553-8195"]},"institutions":[{"id":"https://openalex.org/I144245601","display_name":"Taisho Pharmaceutical (Japan)","ror":"https://ror.org/033nw2736","country_code":"JP","type":"company","lineage":["https://openalex.org/I144245601"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Takao Yoshimizu","raw_affiliation_strings":["Medicinal Research Laboratories, Taisho Pharmaceutical Co., Ltd., Saitama 331-9530, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicinal Research Laboratories, Taisho Pharmaceutical Co., Ltd., Saitama 331-9530, Japan","institution_ids":["https://openalex.org/I144245601"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113821169","display_name":"Akito Yasuhara","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I144245601","display_name":"Taisho Pharmaceutical (Japan)","ror":"https://ror.org/033nw2736","country_code":"JP","type":"company","lineage":["https://openalex.org/I144245601"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Akito Yasuhara","raw_affiliation_strings":["Medicinal Research Laboratories, Taisho Pharmaceutical Co., Ltd., Saitama 331-9530, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicinal Research Laboratories, Taisho Pharmaceutical Co., Ltd., Saitama 331-9530, Japan","institution_ids":["https://openalex.org/I144245601"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083223952","display_name":"Kazunari Sakagami","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I144245601","display_name":"Taisho Pharmaceutical (Japan)","ror":"https://ror.org/033nw2736","country_code":"JP","type":"company","lineage":["https://openalex.org/I144245601"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kazunari Sakagami","raw_affiliation_strings":["Medicinal Research Laboratories, Taisho Pharmaceutical Co., Ltd., Saitama 331-9530, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicinal Research Laboratories, Taisho Pharmaceutical Co., Ltd., Saitama 331-9530, Japan","institution_ids":["https://openalex.org/I144245601"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110113221","display_name":"Shigeru Okuyama","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I144245601","display_name":"Taisho Pharmaceutical (Japan)","ror":"https://ror.org/033nw2736","country_code":"JP","type":"company","lineage":["https://openalex.org/I144245601"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Shigeru Okuyama","raw_affiliation_strings":["Pharmaceutical Business Division, Taisho Pharmaceutical Co., Ltd., Saitama, 331-9530, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Business Division, Taisho Pharmaceutical Co., Ltd., Saitama, 331-9530, Japan","institution_ids":["https://openalex.org/I144245601"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110880571","display_name":"Shigetada Nakanishi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I22299242","display_name":"Kyoto University","ror":"https://ror.org/02kpeqv85","country_code":"JP","type":"education","lineage":["https://openalex.org/I22299242"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Shigetada Nakanishi","raw_affiliation_strings":["Department of Biological Sciences, Kyoto University Faculty of Medicine, Kyoto 660-8501, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biological Sciences, Kyoto University Faculty of Medicine, Kyoto 660-8501, Japan","institution_ids":["https://openalex.org/I22299242"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5113554239","display_name":"Atsuro Nakazato","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I144245601","display_name":"Taisho Pharmaceutical (Japan)","ror":"https://ror.org/033nw2736","country_code":"JP","type":"company","lineage":["https://openalex.org/I144245601"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Atsuro Nakazato","raw_affiliation_strings":["Medicinal Research Laboratories, Taisho Pharmaceutical Co., Ltd., Saitama 331-9530, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicinal Research Laboratories, Taisho Pharmaceutical Co., Ltd., Saitama 331-9530, Japan","institution_ids":["https://openalex.org/I144245601"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5039021133"],"corresponding_institution_ids":["https://openalex.org/I144245601"],"apc_list":{"value":4300,"currency":"USD","value_usd":4300},"apc_paid":null,"fwci":3.506,"has_fulltext":false,"cited_by_count":262,"citation_normalized_percentile":{"value":0.94142534,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":96,"max":100},"biblio":{"volume":"46","issue":"4","first_page":"457","last_page":"467"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.7476000189781189,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.7476000189781189,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.23960000276565552,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11178","display_name":"Receptor Mechanisms and Signaling","score":0.002899999963119626,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/group-ii-metabotropic-glutamate-receptors","display_name":"group II metabotropic glutamate receptors","score":0.9039999842643738},{"id":"https://openalex.org/keywords/mglur2","display_name":"mGluR2","score":0.925000011920929},{"id":"https://openalex.org/keywords/mglur3","display_name":"mGluR3","score":1.0},{"id":"https://openalex.org/keywords/mglur-antagonists","display_name":"mGluR antagonists","score":0.6669999957084656},{"id":"https://openalex.org/keywords/antidepressant-like-effects","display_name":"antidepressant-like effects","score":0.9279999732971191},{"id":"https://openalex.org/keywords/competitive-antagonism","display_name":"competitive antagonism","score":0.8209999799728394},{"id":"https://openalex.org/keywords/ly341495","display_name":"LY341495","score":0.9350000023841858},{"id":"https://openalex.org/keywords/forced-swim-test","display_name":"forced swim test","score":0.781000018119812},{"id":"https://openalex.org/keywords/tail-suspension-test","display_name":"tail suspension test","score":0.9919999837875366},{"id":"https://openalex.org/keywords/social-interaction","display_name":"social interaction","score":0.6690000295639038},{"id":"https://openalex.org/keywords/elevated-plus-maze","display_name":"elevated plus maze","score":0.8149999976158142},{"id":"https://openalex.org/keywords/camp","display_name":"cyclic AMP","score":0.6119999885559082},{"id":"https://openalex.org/keywords/gtpgammas-binding","display_name":"GTPgammaS binding","score":0.6850000023841858}],"concepts":[{"id":"https://openalex.org/C119128870","wikidata":"https://www.wikidata.org/wiki/Q4859538","display_name":"Metabotropic glutamate receptor 2","level":5,"score":0.8964318037033081},{"id":"https://openalex.org/C49051014","wikidata":"https://www.wikidata.org/wiki/Q2033959","display_name":"Metabotropic glutamate receptor","level":4,"score":0.8700188994407654},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.7173944711685181},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6357221603393555},{"id":"https://openalex.org/C2778684643","wikidata":"https://www.wikidata.org/wiki/Q5514740","display_name":"GTPgammaS","level":4,"score":0.5714718699455261},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5514470338821411},{"id":"https://openalex.org/C2781001258","wikidata":"https://www.wikidata.org/wiki/Q7676084","display_name":"Tail suspension test","level":5,"score":0.4982302188873291},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.47769835591316223},{"id":"https://openalex.org/C61174792","wikidata":"https://www.wikidata.org/wiki/Q420510","display_name":"Glutamate receptor","level":3,"score":0.4372379183769226},{"id":"https://openalex.org/C41653306","wikidata":"https://www.wikidata.org/wiki/Q6589190","display_name":"Metabotropic glutamate receptor 5","level":5,"score":0.4261699914932251},{"id":"https://openalex.org/C207951395","wikidata":"https://www.wikidata.org/wiki/Q288431","display_name":"Metabotropic glutamate receptor 1","level":5,"score":0.42471209168434143},{"id":"https://openalex.org/C26702167","wikidata":"https://www.wikidata.org/wiki/Q901988","display_name":"Metabotropic receptor","level":4,"score":0.41129767894744873},{"id":"https://openalex.org/C136569192","wikidata":"https://www.wikidata.org/wiki/Q4880745","display_name":"Behavioural despair test","level":4,"score":0.3409937918186188},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.2694949209690094},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.258935809135437},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.2537049949169159},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.1950187087059021},{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.1719980537891388},{"id":"https://openalex.org/C2781161787","wikidata":"https://www.wikidata.org/wiki/Q48360","display_name":"Hippocampus","level":2,"score":0.06177395582199097}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000928","descriptor_name":"Antidepressive Agents","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D000928","descriptor_name":"Antidepressive Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000928","descriptor_name":"Antidepressive Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001643","descriptor_name":"Bridged Bicyclo Compounds","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D001643","descriptor_name":"Bridged Bicyclo Compounds","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D001643","descriptor_name":"Bridged Bicyclo Compounds","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D003863","descriptor_name":"Depression","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D003863","descriptor_name":"Depression","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D003998","descriptor_name":"Dicarboxylic Acids","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D003998","descriptor_name":"Dicarboxylic Acids","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D003998","descriptor_name":"Dicarboxylic Acids","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006224","descriptor_name":"Cricetinae","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007398","descriptor_name":"Interpersonal Relations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008124","descriptor_name":"Locomotion","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D008124","descriptor_name":"Locomotion","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008813","descriptor_name":"Mice, Inbred ICR","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011485","descriptor_name":"Protein Binding","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D011485","descriptor_name":"Protein Binding","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D016466","descriptor_name":"CHO Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017207","descriptor_name":"Rats, Sprague-Dawley","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017208","descriptor_name":"Rats, Wistar","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018094","descriptor_name":"Receptors, Metabotropic Glutamate","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D018094","descriptor_name":"Receptors, Metabotropic Glutamate","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D018782","descriptor_name":"Maze Learning","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D018782","descriptor_name":"Maze Learning","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.neuropharm.2003.10.009","doi":"https://doi.org/10.1016/j.neuropharm.2003.10.009","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.neuropharm.2003.10.009","pdf_url":null,"source":{"id":"https://openalex.org/S160566677","display_name":"Neuropharmacology","issn_l":"0028-3908","issn":["0028-3908","1873-7064"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-3","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuropharmacology","raw_type":"journal-article"},{"id":"pmid:14975669","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/14975669","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuropharmacology","raw_type":"Comparative Study"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9074000120162964,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":44,"referenced_works":["https://openalex.org/W1487123995","https://openalex.org/W1972183007","https://openalex.org/W1979149627","https://openalex.org/W1990407514","https://openalex.org/W1996855868","https://openalex.org/W2005594217","https://openalex.org/W2008956763","https://openalex.org/W2009077347","https://openalex.org/W2011538551","https://openalex.org/W2013588838","https://openalex.org/W2021097774","https://openalex.org/W2029046909","https://openalex.org/W2040114322","https://openalex.org/W2040775350","https://openalex.org/W2042152382","https://openalex.org/W2043166209","https://openalex.org/W2045628566","https://openalex.org/W2046633134","https://openalex.org/W2050419480","https://openalex.org/W2050493044","https://openalex.org/W2061731402","https://openalex.org/W2066439059","https://openalex.org/W2069192879","https://openalex.org/W2069338515","https://openalex.org/W2078457630","https://openalex.org/W2080529726","https://openalex.org/W2080705534","https://openalex.org/W2082049028","https://openalex.org/W2082406942","https://openalex.org/W2091064555","https://openalex.org/W2093639447","https://openalex.org/W2103069362","https://openalex.org/W2103903531","https://openalex.org/W2106042714","https://openalex.org/W2111478092","https://openalex.org/W2127698314","https://openalex.org/W2130227962","https://openalex.org/W2131167630","https://openalex.org/W2140178312","https://openalex.org/W2161324168","https://openalex.org/W2161891468","https://openalex.org/W2167891371","https://openalex.org/W2168367599","https://openalex.org/W6684862384"],"related_works":["https://openalex.org/W2010734130","https://openalex.org/W2036478654","https://openalex.org/W2007334584","https://openalex.org/W2066595863","https://openalex.org/W2052617026","https://openalex.org/W2088572321","https://openalex.org/W2037809388","https://openalex.org/W2048144741","https://openalex.org/W1964601445","https://openalex.org/W1980654104"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":12},{"year":2022,"cited_by_count":14},{"year":2021,"cited_by_count":14},{"year":2020,"cited_by_count":11},{"year":2019,"cited_by_count":12},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":8},{"year":2016,"cited_by_count":13},{"year":2015,"cited_by_count":15},{"year":2014,"cited_by_count":12},{"year":2013,"cited_by_count":19},{"year":2012,"cited_by_count":16}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}